NATERA, INC. Increase (Decrease) in Contract with Customer, Liability
NATERA, INC. (NTRA) reported Increase (Decrease) in Contract with Customer, Liability of $14.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-07
- NATERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $2.79M, a 253.36% increase year-over-year.
- NATERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $11.88M, a 1670.79% increase year-over-year.
- NATERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $1.11M, a 37.71% decline year-over-year.
- NATERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $178.00K.
- NATERA, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $2.75M, a 223.12% increase from fiscal 2024.
- NATERA, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was $852.00K, a 82.83% decline from fiscal 2023.
- NATERA, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $4.96M, a 141.34% increase from fiscal 2022.
- NATERA, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was $2.06M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $14.67M 10-Q · filed 2026-08-07 | $15.79M derived: sum of 3 quarters · filed 2026-08-07 | $15.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $11.88M 10-Q · filed 2026-05-08 | $13.00M derived: sum of 2 quarters · filed 2026-05-08 | $13.18M derived: sum of 3 quarters · filed 2026-05-08 | $13.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.29M derived: sum of 2 quarters · filed 2026-02-27 | $2.08M derived: sum of 3 quarters · filed 2026-08-07 | $2.75M 10-K · filed 2026-02-27 |
| 2025-09-30 | $178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $967.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.64M 10-Q · filed 2025-11-07 | $3.43M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $789.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.46M 10-Q · filed 2026-08-07 | $3.25M derived: sum of 3 quarters · filed 2026-08-07 | $1.27M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $671.00K 10-Q · filed 2026-05-08 | $2.46M derived: sum of 2 quarters · filed 2026-05-08 | $479.00K derived: sum of 3 quarters · filed 2026-05-08 | $730.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$192.00K derived: sum of 2 quarters · filed 2026-02-27 | $59.00K derived: sum of 3 quarters · filed 2026-02-27 | $852.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.73M derived: sum of 2 quarters · filed 2025-11-07 | -$938.00K 10-Q · filed 2025-11-07 | -$1.24M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.04M 10-Q · filed 2025-08-08 | $738.00K derived: sum of 3 quarters · filed 2026-02-27 | -$362.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $793.00K 10-Q · filed 2025-05-09 | $487.00K derived: sum of 2 quarters · filed 2026-02-27 | -$613.00K derived: sum of 3 quarters · filed 2026-02-27 | -$1.56M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.41M derived: sum of 2 quarters · filed 2026-02-27 | -$2.35M derived: sum of 3 quarters · filed 2026-02-27 | $4.96M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.04M derived: sum of 2 quarters · filed 2024-11-12 | $5.27M 10-Q · filed 2024-11-12 | $7.71M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$944.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $6.37M 10-Q · filed 2024-08-09 | $8.81M derived: sum of 3 quarters · filed 2025-02-28 | $415.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $7.31M 10-Q · filed 2024-05-10 | $9.75M derived: sum of 2 quarters · filed 2025-02-28 | $1.36M derived: sum of 3 quarters · filed 2025-02-28 | $3.63M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$5.95M derived: sum of 2 quarters · filed 2025-02-28 | -$3.68M derived: sum of 3 quarters · filed 2025-02-28 | $2.06M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$8.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$6.12M derived: sum of 2 quarters · filed 2023-11-09 | -$384.00K 10-Q · filed 2023-11-09 | -$4.04M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $8.01M 10-Q · filed 2023-08-04 | $4.36M derived: sum of 3 quarters · filed 2024-02-29 | $2.52M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.74M 10-Q · filed 2023-05-10 | $2.08M derived: sum of 2 quarters · filed 2024-02-29 | $247.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.57M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$5.49M derived: sum of 2 quarters · filed 2024-02-29 | -$4.16M derived: sum of 3 quarters · filed 2024-02-29 | -$44.21M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$512.00K derived: sum of 2 quarters · filed 2022-11-09 | -$40.56M 10-Q · filed 2022-11-09 | -$41.98M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$38.72M 10-Q · filed 2022-08-05 | -$40.15M derived: sum of 3 quarters · filed 2023-03-01 | -$40.72M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$40.05M 10-Q · filed 2022-05-06 | -$41.47M derived: sum of 2 quarters · filed 2023-03-01 | -$42.04M derived: sum of 3 quarters · filed 2023-03-01 | -$44.11M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.00M derived: sum of 2 quarters · filed 2023-03-01 | -$4.06M derived: sum of 3 quarters · filed 2023-03-01 | -$6.89M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$570.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$2.64M derived: sum of 2 quarters · filed 2021-11-05 | -$5.47M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$4.90M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | -$2.83M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $40.85M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $42.86M 10-Q · filed 2020-11-06 | $78.36M derived: sum of 2 quarters · filed 2020-11-06 | $78.79M derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $35.49M 10-Q · filed 2020-08-07 | $35.93M derived: sum of 2 quarters · filed 2020-08-07 | ||
| 2019-03-31 | $437.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $42.77M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $846.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |